Furen Group Pharmaceutical Co.,Ltd. Posted 181.4 Million Yuan Net Loss in First Quarter of 2022

Furen Group Pharmaceutical Co.,Ltd. (辅仁药业集团制药股份有限公司) (600781.SH) reported a net loss of 181.4 million yuan in the first quarter of 2022, widening 359.9% year-on-year.

Meanwhile, the company posted 349.3 million yuan in revenue, down 29.3% year-on-year.

At the end of the reporting period, it had 8.2 billion yuan in total assets and 7.6 billion yuan in total liabilities, with a liability-to-asset ratio of 92.9%.